COVID-19
CRC Press (Verlag)
978-1-032-04063-9 (ISBN)
The COVID-19 pandemic has affected the entire world in an unprecedented way, and this book provides an overview of the historical facts as well as ongoing approaches to tackle the COVID-19 pandemic. Experts of the respective domains provide details on anti-SARS-CoV-2 drug strategies, including repurposing drugs used for other indications and the development of novel drugs looking at different approaches to target virus entry and replication. COVID-19 vaccine development based on inactivated and attenuated live virus, protein subunit and peptide-based vaccines and utilization of vaccine candidates based on viral vectors, DNA and RNA are presented for both preclinical studies and clinical trials.
Key Features
Explains the background of the COVID-19 pandemic, the current progress in the development of treatments and prevention of COVID-19 including future aspects of dealing with the pandemic
Serves as a timely repository of knowledge on COVID-19 for researchers and medical professionals engaged in its management
Dr. Debmalya Barh is currently a Visiting Full Professor (Titular, Grade-E) at the Department of Genetics, Ecology and Evolution, Institute of Biological Sciences (ICB), Federal University of Minas Gerais (UFMG), Brazil. He is also an honorary Scientist at Institute of Integrative Omics and Applied Biotechnology (IIOAB), India. Dr. Kenneth Lundstrom is currently the CEO of PanTherapeutics in Lausanne, Switzerland.He serves on editorial boards of various journals including Biomedicines and Viruses, and acts as Editor-in-chief for Frontiers in Translational Virology.
Chapter 1 Coronavirus epidemics and the current COVID-19 pandemic
Chapter 2 Biology of Coronaviruses and Predicted Origin of SARS-CoV-2
Chapter 3 Therapeutic Challenges in COVID-19
Chapter 4 Prevention and Control Strategies for COVID-19 Pandemic
Chapter 5 Global Focus and Interdisciplinary Approaches in COVID-19 Research and Their Outcomes
Chapter 6 The evolution of COVID-19 diagnostics
Chapter 7 Drug repurposing and novel antiviral drugs for COVID-19 management
Chapter 8 Convalescent Plasma and Antibody Therapy in COVID-19
Chapter 9 Application Stem Cell and Exosome Based Therapy in COVID-19
Chapter 10 Host and Pathogen-Specific Drug Targets in COVID-19
Chapter 11 Computational biology and bioinformatics in anti-SARS-CoV-2 drug development
Chapter 12 Nanomaterials in COVID-19 drug development
Chapter 13 Vaccine Development Strategies and the Current Status of COVID-19 Vaccines
Chapter 14 Clinical trials of COVID-19 therapeutics and vaccines: history, current status, and limitations
Chapter 15 Lessons Learned from COVID-19 and Their Implementations for Future Pandemics
| Erscheinungsdatum | 08.03.2022 |
|---|---|
| Zusatzinfo | 1 Tables, color; 26 Tables, black and white; 11 Line drawings, color; 19 Halftones, color; 2 Halftones, black and white; 30 Illustrations, color; 2 Illustrations, black and white |
| Verlagsort | London |
| Sprache | englisch |
| Maße | 178 x 254 mm |
| Gewicht | 607 g |
| Themenwelt | Medizin / Pharmazie ► Allgemeines / Lexika |
| Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
| ISBN-10 | 1-032-04063-7 / 1032040637 |
| ISBN-13 | 978-1-032-04063-9 / 9781032040639 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
